公司简介

Castle Biosciences develops and validates diagnostic tests and technologies for the treatment of cancer.

主要成员

Derek Maetzold、Mara Aspinall、Dan Bradbury

产品/服务

• 肿瘤基因组

Cutaneous Melanoma	Test identifies Stage I or II patients at high risk of metastasis
Uveal Melanona.	Highly accurate prognostic tool is standard of care in eye cancer.

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2008-10	未披露	undisclosed amount
B轮	2009-03	未披露	$935.9K
B+轮	2010-03	未披露	$1.12M
C轮	2012-10	未披露	$1.34M
C+轮	2013-05	未披露	$1.51M
D轮	2013-11	未披露	$1M
D+轮	2014-05	未披露	$1M
E轮	2014-08	HealthQuest Capital	$11.8M
债权融资	2015-04	未披露	$6M
F轮	2015-07	Industry Ventures	$11.7M
债权融资	2016-03	未披露	$14M

关联公司